Antibody response to tetravalent influenza subunit vaccine in patients infected with human immunodeficiency virus type 1

International Journal of Antimicrobial Agents

Volumn 6, Issue 4, 1996, Pages 195-200

  Schneider, Margriet M E ^a   Sprenger, Marc J W ^b   Hoepelman, I M ^a   Van Der Graaf, Yolanda ^c   Borleffs, Jan C C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

AIDS; CD4 cell count; HIV seropositivity; Influenza vaccine; Vaccination

Indexed keywords

CD4 ANTIGEN; HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA VACCINATION; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; VIRUS STRAIN;

EID: 0030009556     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-8579(95)00038-0     Document Type: Article

References (25)

1. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics. Arch Intern Med. 1982;142:85-89.
2. Prevention and control of influenza. MMWR 1988;37:361-4,369-73. JAMA 1988;260:318-322.
3. Prevention and control of influenza. MMWR 1988;37:361-4,369-73. JAMA 1988;260:318-322.
4. Influenza - United States, 1989-90 and 1990-91 seasons. MMWR 1992;41:SS3, 35-46.
5. Sprenger MJW, Mulder PGH, Beyer WEP, Van Strik R, Masurel N. Impact of influenza on mortality regarding age and entity or underlying disease, during the period 1967 to 1989. Int J Epidemiol 1193;22(2):333-339.
6. Cohen JP, Macauley. Susceptibility to influenza A in HIV-positive patients. JAMA 1989;261:245.
7. Rose DN, Schechter CB, Sacks HS. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. Am J Med 1993;94:160-168.
8. Thurn JR, Henry K. Influenza A pneumonitis in a patient infected with the human immunodeficiency virus (HIV). Chest 1989; 95:807-810.
9. Safrin S, Rush JD, Mills J. Influenza in patients with human immunodeficiency virus infection. Chest 1990;98:33-37.
10. Prevention and control of influenza, recommendations of the Immunization Practices Advisory Committee. MMWR 1992; 41:RR9-17.
11. Huang KL, Ruben FL, Rinaldo CR, Kingsley L, Lyter DW, Ho M. Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA 1987;257:2047-2050.
12. Nelson KE, Clements ML, Miotti P, Cohn S, Polk BF. The influence human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Intern Med. 1988;109:383-388.
13. Kroon FP, Van Dissel JT, De Jong JC, Van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994;8:469-476.
14. Ragni MV, Ruben FL, Winkelstein A, Spero JA, Bontempo FA, Lewis JH. Anti-body responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus infection. J Lab Clin Med. 1987;109:545-549.
15. Miotti PG, Nelson KE, Dallabetta GA, Farzadegan H, Margolick J et al. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA 1989;262:779-783.
16. Birx DL, Rhoads JL, Wright JC, Burke DS, Redfield RR. Immunologic parameters in early stage HIV-seropositive subjects associated with vaccine responsiveness. J Acq Immun Def Synd 1991;4:188-196.
17. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(suppl 1S):1S-15S.
18. Masurel N, Ophof P, De Jong P. Antibody response to immunization with influenza A/USSR/77(H1N1) virus in young individuals primed or unprimed for A/New Jersey/76(H1N1)virus. J Hyg. 1981;87:201.
19. Berlin BS, McQueen JL, Minuse E et al. A method for increasing the sensitivity of the hemagglutination-inhibition test with equine influenza virus. Virology 1963;21:665.
20. Masurel N, Laufer J. A one year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection. J Hyg 1984;92:263(18,19).
21. Beyer WEP, Teunissen MWE, Diepersloot RJA, Masurel N. Immunogenicity and reactogenicity of two doses of a trivalent influenza split vaccine. An open randomized study in health, unprotected, adult volunteers. J Drug Ther Res 1986;11:369.
22. SAS/STAT guide for personal computers, version 6 ed. SAS Institute, Gary, NC, 1985.
23. Palache AM, Beyer WEP, Lüchters G, Völker R, Sprenger MJW, Masurel N. Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature. Vaccine 1993;9:892-908.
24. Beyer WEP, Palache AM, Baljet M, Masurel N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 1989;7:385-394.
25. Tasker S, O'Brien W, Rosetti R et al. Effects of influenza vaccination in HIV infected patients: a double-blind, placebo-controled trial. Abstract LB11, 35th Intersci Conf Antimicrobial Agents and Chemotherapy, 1995.